We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Single-cell characterisation of tissue homing CD4 + and CD8 + T cell clones in immune-mediated refractory arthritis

    Background

    Immune-mediated arthritis is a group of autoinflammatory diseases, where the patient’s own immune system attacks and destroys synovial...

    Dipabarna Bhattacharya, Jason Theodoropoulos, ... Tapio Lönnberg in Molecular Medicine
    Article Open access 09 April 2024
  2. Circulating memory PD-1+CD8+ T cells and PD-1+CD8+T/PD-1+CD4+T cell ratio predict response and outcome to immunotherapy in advanced gastric cancer patients

    Background

    Limited benefit population of immunotherapy makes it urgent to select effective biomarkers for screening appropriate treatment population....

    Jiang Liu, Degan Liu, ... Wen**g Xu in Cancer Cell International
    Article Open access 16 November 2023
  3. Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors

    CD4 + T cells play key roles in a range of immune responses, either as direct effectors or through accessory cells, including CD8 + T lymphocytes. In...

    Spencer E. Brightman, Angelica Becker, ... Stephen P. Schoenberger in Nature Immunology
    Article Open access 03 July 2023
  4. Evaluating the immunologically “cold” tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4 + and CD8 + T cells in breast cancer mouse models

    Background

    Immune-positron emission tomography (PET) imaging with tracers that target CD8 and granzyme B has shown promise in predicting the...

    Yun Lu, Hailey A. Houson, ... Anna G. Sorace in Breast Cancer Research
    Article Open access 25 June 2024
  5. Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma

    Despite no apparent defects in T cell priming and recruitment to tumors, a large subset of T cell rich tumors fail to respond to immune checkpoint...

    Assaf Magen, Pauline Hamon, ... Miriam Merad in Nature Medicine
    Article 15 June 2023
  6. Phenotypic and Functional Characterization of Memory CD4+ and CD8+ T Cells After Antigenic Stimulation

    The encounter of T cells with the antigen through the interaction of T cell receptors with peptides and major histocompatibility complex (MHC)...
    Carolina do Prado Servian, Letícia Carrijo Masson, Simone Gonçalves Fonseca in Immune Homeostasis
    Protocol 2024
  7. Comparative analysis of the DNA methylation landscape in CD4, CD8, and B memory lineages

    Background

    There is considerable evidence that epigenetic mechanisms and DNA methylation are critical drivers of immune cell lineage differentiation...

    Ze Zhang, Rondi Butler, ... Lucas A. Salas in Clinical Epigenetics
    Article Open access 15 December 2022
  8. S1P/S1PR1 signaling differentially regulates the allogeneic response of CD4 and CD8 T cells by modulating mitochondrial fission

    Graft-versus-host disease (GVHD) significantly contributes to patient morbidity and mortality after allogeneic hematopoietic cell transplantation...

    Linlu Tian, Yongxia Wu, ... Xue-Zhong Yu in Cellular & Molecular Immunology
    Article 08 September 2022
  9. Posttranscriptional Events Orchestrate Immune Homeostasis of CD8+ T Cells

    Maintaining immune homeostasis is instrumental for host health. Immune cells, such as T cells, are instrumental for the eradication of pathogenic...
    Julian J. Freen-van Heeren in Immune Homeostasis
    Protocol 2024
  10. AMPKα2 promotes tumor immune escape by inducing CD8+ T-cell exhaustion and CD4+ Treg cell formation in liver hepatocellular carcinoma

    Background

    Adenosine monophosphate-activated protein kinase (AMPK) is associated with the development of liver hepatocellular carcinoma (LIHC)....

    Yan Ouyang, Yan Gu, ... Shichao Zhang in BMC Cancer
    Article Open access 01 March 2024
  11. CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors

    CD4 + T cells can "help” or "license” conventional type 1 dendritic cells (cDC1s) to induce CD8 + cytotoxic T lymphocyte (CTL) anticancer responses, as...

    **n Lei, Daniël C. de Groot, ... Yanling **ao in Cellular & Molecular Immunology
    Article Open access 21 February 2024
  12. Human T lymphocytes at tumor sites

    CD4 + and CD8 + T lymphocytes mediate most of the adaptive immune response against tumors. Naïve T lymphocytes specific for tumor antigens are primed...

    Samuele Notarbartolo, Sergio Abrignani in Seminars in Immunopathology
    Article Open access 16 November 2022
  13. CD40 ligand stimulation affects the number and memory phenotypes of human peripheral CD8+ T cells

    Background

    CD40L is primarily expressed on activated CD4 + T cells and binds to CD40 which is expressed by various cells including dendritic cells,...

    Haeyoun Choi, Hyun-Joo Lee, ... Tai-Gyu Kim in BMC Immunology
    Article Open access 30 June 2023
  14. Thymoquinone modifies CD4+:CD8+ ratio without affecting tumor necrosis factor-α and interleukin-1β levels in Wallerian degeneration crush injury rat model

    Wallerian degeneration following nerve injury not only suppresses CD4+ T-cell responses but also promotes pro-inflammatory immunological responses...

    Valentinus Besin, Abdul Hafid Bajamal, ... Farizky Martriano Humardani in Neuroscience and Behavioral Physiology
    Article 06 January 2024
  15. CD8+ T cell-based cancer immunotherapy

    The immune system in humans is a defense department against both exogenous and endogenous hazards, where CD8 + T cells play a crucial role in opposing...

    Yanxia Chen, Dingning Yu, ... Zhimin Tao in Journal of Translational Medicine
    Article Open access 29 April 2024
  16. Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies

    Background

    The search for biomarkers to identify suitable candidates for immune checkpoint inhibitor (ICI) therapy remains ongoing. We evaluate how...

    Joao Gorgulho, Christoph Roderburg, ... Tom Luedde in British Journal of Cancer
    Article Open access 17 January 2024
  17. Persistence and enrichment of dominant T cell clonotypes in expanded tumor-infiltrating lymphocytes of breast cancer

    Background

    Adoptive cell therapy using tumor-infiltrating lymphocytes (TILs) has shown promising results in cancer treatment, including breast cancer....

    Baknoon Ham, Su Yeon Kim, ... Junyoung Shin in British Journal of Cancer
    Article 15 May 2024
  18. The effect of metformin on senescence of T lymphocytes

    Background

    Immunosenescence occurs as people age, leading to an increased incidence of age-related diseases. The number of senescent T cells also...

    Jia Yang, Hai-Cheng Liu, ... Hai Hong in Immunity & Ageing
    Article Open access 12 December 2023
  19. CD4 T-cell aging exacerbates neuroinflammation in a late-onset mouse model of amyotrophic lateral sclerosis

    Amyotrophic lateral sclerosis (ALS) is an adult-onset progressive neurodegenerative disorder characterized by the loss of upper and lower motor...

    Shir Zaccai, Anna Nemirovsky, ... Alon Monsonego in Journal of Neuroinflammation
    Article Open access 11 January 2024
  20. CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential

    CD8 T cells play crucial roles in immune surveillance and defense against infections and cancer. After encountering antigenic stimulation, naïve CD8...

    Choong-Hyun Koh, Suyoung Lee, ... Yeonseok Chung in Experimental & Molecular Medicine
    Article Open access 01 November 2023
Did you find what you were looking for? Share feedback.